Reynolds prepares to appeal against US FDA denial of Vuse menthol PMTAs

RJ Reynolds Vapor Company plans to challenge the US Food and Drug Administration (FDA)’s rejection of its Vuse menthol vape cartridges, joining a judicial fight that has had mixed results for other companies.

Reynolds will ask an appeals court to stay the FDA’s decision to deny two pre-market tobacco product applications (PMTAs) submitted for the company’s Vuse Vibe Tank Menthol 3% and its Vuse Ciro Cartridge Menthol 1.5%. The promised legal challenge comes amid conflicting opinions about the FDA’s rejection of Reynolds’s PMTAs and a legal landscape that has seen some companies win and others lose.


Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us